ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Effect of gliclazide on cardiovascular risk factors involved in split-dose streptozotocin induced neonatal rat model: a chronic study

Journal: International Journal of Basic & Clinical Pharmacology (Vol.1, No. 3)

Publication Date:

Authors : ;

Page : 196-201

Keywords : n-STZ rat model; streptozotocin; gliclazide; diabetes; hypertension; cardiovascular risk factors;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Background: The present study aimed at evaluating the effect of gliclazide on cardiovascular risk factors involved in type 2 diabetes mellitus using n-STZ rat model on a long term basis. Methods: The diabetic model was developed using a split dose of streptozotocin (50 mg/kg) intraperitoneally on 2nd and 3rd postnatal days. The diabetic rats were treated orally with gliclazide suspension at the dose of 10 mg/kg for 90 days. Cardiovascular risk factors such as systolic blood pressure, heart rate, lipid profile, creatine kinase and lactate dehydrogenase were evaluated at regular intervals along with fasting blood glucose (FBG) and oral glucose tolerance test. Results: Gliclazide did not alter FBG however improved the impaired glucose tolerance. The gliclazide treated rats did not develop hypertension and there was a significant difference (p

Last modified: 2013-03-02 19:30:29